Lacidipine

Spécifications

103890-78-4Numéro CAS

638-759-0Numéro CE

diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylateNom IUPAC

C26H33NO6Formule chimique

455.5 g/molMasse molaire

Lacidipine; 103890-78-4; Lacipil; Motens; GR-43659X; Lacidipino; Lacidipinum; GR 43659X; Molap; DTXSID1046429; diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate; DTXCID9026429; 260080034N; 3,5-diethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; 3,5-diethyl 4-(2-((1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; diethyl 2,6-dimethyl-4-(2-((E)-3-((2-methylpropan-2-yl)oxy)-3-oxoprop-1-enyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate; RefChem:924456; C08CA09; diethyl 2,6-dimethyl-4-(2-((E)-2-((2-methylpropan-2-yl)oxycarbonyl)ethenyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate; MFCD00865936; GX-1048; diethyl (E)-4-(2-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; (E)-Diethyl 4-(2-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; diethyl 2,6-dimethyl-4-[2-[(Z)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate; C26H33NO6; Lacimen; 3,5-Pyridinedicarboxylic acid, 4-(2-(3-(1,1-dimethylethoxy)-3-oxo-1-propenyl)phenyl)-1,4-dihydro-2,6-dimethyl-, diethyl ester, (E)-; 4-(o-((E)-2-Carboxyvinyl)phenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, 4-tert-butyl diethyl ester; Lacidipinum [Latin]; Lacidipino [Spanish]; Lacirex; (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester; SMR000466342; CAS-103890-78-4; SR-05000001445; GR 43659 X; Viapres; Lacidipine (Lacipil, Motens); Lacidipine [USAN:INN:BAN]; NCGC00164545-01; 4-[O-[(E)-2-Carboxyvinyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, 4-tert-butyl diethyl ester; Motens (TN); SN-305; UNII-260080034N; Lacidipine (Standard); LACIDIPINE [MI]; LACIDIPINE [INN]; LACIDIPINE [JAN]; Lacidipine (USAN/INN); LACIDIPINE [USAN]; LACIDIPINE [VANDF]; LACIDIPINE [MART.]; Lacidipine Impurity Standard; LACIDIPINE [WHO-DD]; Lacipil, Motens, Lacidipine; SCHEMBL49277; MLS000759454; MLS001424282; CHEMBL460291; Lacidipine - Bio-X trade mark; orb1227086; orb1308604; CHEMBL1728809; SCHEMBL13287288; SCHEMBL29352892; CHEBI:94480; GTPL11740; HY-B0347R; CHEBI:135737; BDBM642517; HMS2052F03; HMS2089K22; HMS3713D20; HMS3884I18; HMS5080H13; HMS6018J14; (E)-Diethyl4-(2-(3-(Tert-Butoxy)-3-Oxoprop-1-En-1-Yl)Phenyl)-2,6-Dimethyl-1,4-Dihydropyridine-3,5-Dicarboxylate; GR43659X; HY-B0347; MSK10661; Tox21_112174; EBC-08016; GX1048; s1994; AKOS005066844; Tox21_112174_1; CCG-101153; CCG-220579; DB09236; FL24824; GR-43 659X; GX 1048; HS-0086; NC00403; US20230414632, Compound I-a; NCGC00263529-01; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-(3-(1,1-dimethylethoxy)-3-oxo-1-propenyl)phenyl)-, diethyl ester, (E)-; AC-11008; AC-33195; BL164603; CPD000466342; diethyl 4-[2-[(E)-3-tert-butoxy-3-oxo-prop-1-enyl]phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; PD002941; SY103680; L0276; NS00004885; SW219840-1; C71162; D04657; SBI-0634384.0001; AB00698350-05; AB01275445-01; AB01275445_02; EN300-22411579; F826014; Q1163827; SR-05000001445-1; SR-05000001445-2; BRD-K05851096-001-01-9; BRD-K43586850-001-02-9; Diethyl (E)-4-[2-[3-(tert-Butoxy)-3-oxo-1-propen-1-yl]phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; diethyl 4-{2-[(1E)-3-tert-butoxy-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylateSynonymes